Simplex Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-519
| Closed | -$8K | – | 10117 |
|
|
2024
Q1 | $8K | Sell |
519
-12,747
| -96% | -$196K | ﹤0.01% | 7791 |
|
|
2023
Q4 | $213K | Buy |
13,266
+12,158
| +1,097% | +$155K | ﹤0.01% | 4627 |
|
|
2023
Q3 | $14K | Buy |
1,108
+248
| +29% | +$3.42K | ﹤0.01% | 6959 |
|
|
2023
Q2 | $12K | Buy |
860
+215
| +33% | +$3.08K | ﹤0.01% | 7281 |
|
|
2023
Q1 | $9K | Buy |
+645
| New | +$10.8K | ﹤0.01% | 7674 |
|
|
2022
Q1 | – | Sell |
-2,391
| Closed | -$20.3K | – | 11641 |
|
|
2021
Q4 | $23K | Buy |
2,391
+871
| +57% | +$16.4K | ﹤0.01% | 8226 |
|
|
2021
Q3 | $56K | Sell |
1,520
-200
| -12% | -$6.38K | ﹤0.01% | 7398 |
|
|
2021
Q2 | $62K | Buy |
+1,720
| New | +$66.6K | ﹤0.01% | 7394 |
|
|
2021
Q1 | – | Sell |
-815
| Closed | -$37.9K | – | 10302 |
|
|
2020
Q4 | $46K | Buy |
+815
| New | +$48.3K | ﹤0.01% | 6286 |
|
|
2020
Q2 | – | Sell |
-2,083
| Closed | -$111K | – | 8556 |
|
|
2020
Q1 | $85K | Sell |
2,083
-10,101
| -83% | -$561K | ﹤0.01% | 4549 |
|
|
2019
Q4 | $758K | Buy |
12,184
+9,920
| +438% | +$471K | ﹤0.01% | 2347 |
|
|
2019
Q3 | $76K | Buy |
+2,264
| New | +$67K | ﹤0.01% | 4620 |
|
Other funds holding DCPH
Simplex Trading's DCPH Position: Q2 2024 in Review
Simplex Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 519 shares — an estimated $8K sold.
Simplex Trading first reported a position in DCPH in Q3 2019 and held it in 12 quarters. The position peaked at $758K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Simplex Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Simplex Trading sold 519 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $8K.
- Simplex Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
- Simplex Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $758K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.